Literature DB >> 24664129

Uterine peristalsis before embryo transfer affects the chance of clinical pregnancy in fresh and frozen-thawed embryo transfer cycles.

L Zhu1, H S Che, L Xiao, Y P Li.   

Abstract

STUDY QUESTION: Does uterine peristalsis influence the chance of clinical pregnancy in an embryo transfer cycle? SUMMARY ANSWER: The uterine peristaltic wave frequency before embryo transfer is inversely related to the clinical pregnancy rates in fresh and frozen-thawed embryo transfer cycles. WHAT IS KNOWN ALREADY: Uterine peristalsis participates in regulating fluid migration after mock embryo transfer, but whether it could potentially influence pregnancy outcomes had remained unclear. STUDY DESIGN, SIZE, DURATION: This prospective cohort study included a total of 292 infertile women and was conducted between March 2013 and August 2013. PARTICIPANTS/MATERIALS, SETTING,
METHODS: Patients underwent fresh embryo transfer in a fresh stimulation cycle with a long down-regulation protocol, a natural frozen-thawed embryo transfer cycle or an artificial frozen-thawed embryo transfer cycle. Uterine peristaltic activity was assessed before embryo transfer by transvaginal ultrasonography. MAIN RESULTS AND THE ROLE OF CHANCE: The uterine peristaltic wave frequencies of most patients were between 1.1 and 3.0 waves/min before embryo transfer (ET). The clinical pregnancy rate was the highest when <2.0 waves/min was observed and it decreased with an increasing wave frequency thereafter, with an especially dramatic decrease with >3.0 waves/min. Uterine peristaltic wave frequencies of the non-pregnant patient group were higher than that of the clinically-pregnant patient group in all types of transfer, fresh embryo transfer, natural FET or artificial FET cycle. Binary logistic regression analysis demonstrated that the association between uterine peristaltic wave frequency before embryo transfer and clinical pregnancy was independently significant (odds ratio: 0.49; 95% confidence interval: 0.34-0.70, P < 0.001). LIMITATIONS, REASONS FOR CAUTION: Uterine peristalsis after embryo transfer was not observed in case any possible negative effect of the observation disturbed embryo implantation or caused psychological stress. Uterine peristalsis after embryo transfer may differ from that before embryo transfer. Another limitation of the present study was the lack of uterine peristaltic wave type analysis which is also an important parameter to assess uterine activity. WIDER IMPLICATIONS OF THE
FINDINGS: Patients with uterine peristalsis of <3.0 waves/min before embryo transfer had a higher chance of pregnancy compared with those with higher frequencies. This could be a promising quantitative marker of uterine receptivity and pregnancy outcome in an embryo transfer cycle. The predictive validity of the cut-off value needs to be tested in further study. STUDY FUNDING/COMPETING INTEREST(S): The study is supported by Hunan Provincial Innovation Foundation for Postgraduates. The authors declare that they have no competing interests in this study.

Entities:  

Keywords:  assisted reproductive technology; clinical pregnancy; uterine peristalsis; uterine receptivity

Mesh:

Year:  2014        PMID: 24664129     DOI: 10.1093/humrep/deu058

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  19 in total

1.  Visual inspection of transvaginal ultrasound videos to characterize uterine peristalsis: an inter-observer agreement study.

Authors:  N P M Kuijsters; F Sammali; C Rabotti; Y Huang; M Mischi; B C Schoot
Journal:  J Ultrasound       Date:  2019-02-15

2.  Sub-endometrial contractility or computer-enhanced 3-D modeling scoring of the endometrium before embryo transfer: are they better than measuring endometrial thickness?

Authors:  Nivin Samara; Robert F Casper; Rawad Bassil; Mahvash Shere; Eran Barzilay; Raoul Orvieto; Jigal Haas
Journal:  J Assist Reprod Genet       Date:  2018-10-25       Impact factor: 3.412

Review 3.  Oxytocin antagonists for assisted reproduction.

Authors:  Laurentiu Craciunas; Nikolaos Tsampras; Martina Kollmann; Nick Raine-Fenning; Meenakshi Choudhary
Journal:  Cochrane Database Syst Rev       Date:  2021-09-01

4.  The ElectroUteroGraph: A Novel Tool for Assessing Uterine Contractions of Non-Pregnant Women.

Authors:  Julius Georgiou; Konstantinos Lekkas; Giorgos Varnava; Marios Sophocleous; Andreas Michaelides; Vasilios Tanos
Journal:  IEEE Open J Eng Med Biol       Date:  2022-03-15

Review 5.  Artificial Intelligence in the Assessment of Female Reproductive Function Using Ultrasound: A Review.

Authors:  Zhiyi Chen; Ziyao Wang; Meng Du; Zhenyu Liu
Journal:  J Ultrasound Med       Date:  2021-09-15       Impact factor: 2.754

6.  Comparison of frozen-thawed embryo transfer protocols in patients with previous cycle cancellation due to uterine peristalsis: a pilot study

Authors:  İlknur Selvi; Mehmet Erdem; Erhan Demirdağ; Funda Cevher; Cengiz Karakaya; Ahmet Erdem
Journal:  Turk J Med Sci       Date:  2021-06-28       Impact factor: 0.973

Review 7.  Ectopic pregnancy secondary to in vitro fertilisation-embryo transfer: pathogenic mechanisms and management strategies.

Authors:  Bassem Refaat; Elizabeth Dalton; William L Ledger
Journal:  Reprod Biol Endocrinol       Date:  2015-04-12       Impact factor: 5.211

8.  Effect of Natural Cycle Endometrial Preparation for Frozen-Thawed Embryo Transfer in Patients with Advanced Endometriosis.

Authors:  Haiyan Guo; Yun Wang; Qiuju Chen; Weiran Chai; Qifeng Lv; Yanping Kuang
Journal:  Med Sci Monit       Date:  2016-11-27

9.  The abnormal expression of oxytocin receptors in the uterine junctional zone in women with endometriosis.

Authors:  Miaomaio Huang; Xuqing Li; Peipei Guo; Zhaojuan Yu; Yuting Xu; Zhaolian Wei
Journal:  Reprod Biol Endocrinol       Date:  2017-01-03       Impact factor: 5.211

10.  A double-blinded, randomized, placebo-controlled trial assessing the effects of nifedipine on embryo transfer: Study protocol.

Authors:  Kelvin Kl Ng; Genia Rozen; Tanya Stewart; Franca Agresta; Alex Polyakov
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.